# Telix Pharmaceuticals Ltd: Form 6-K, filed Apr 7, 2026

- Company: [Telix Pharmaceuticals Ltd](/companies/tlx.md) (CIK 2007191)
- Form: 6-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 06:27 ET
- Period: 2026-03-31
- Accession: 0001628280-26-023982
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2007191/000162828026023982/telix-6kforq1businessrelea.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007191/000162828026023982/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007191/000162828026023982/telix-6kforq1businessrelea.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-023982. Last ingested by Listed: Oct 29, 2026, 16:54 ET. No prices; not investment advice.